L01XX Other antineoplastic agents

PheWeb

RX_L01XX

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L01XX

1289

Check pre-conditions, main-only, mode, ICD version None

1011

Check minimum number of events

Min. number of events 3

1011

Include endpoints None

1011

RX_L01XX

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L01XX Other antineoplastic agents based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	979	465	514
Unadjusted prevalence (%)	0.32	0.27	0.38
Mean age at first event (years)	66.10	65.18	66.94

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.06	4.94 [3.41, 7.16]	2.9e-17	205
15 years	0.01	1.83 [1.23, 2.73]	2.9e-3	72
5 years	0.00	4.40 [3.02, 6.39]	8.9e-15	89
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits:

Survival analyses between endpoints

↥

Plot

before L01XX Other antineoplastic agents
after L01XX Other antineoplastic agents

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L01XX Other antineoplastic agents

↥